Ligand Pharmaceuticals (LGND) Jumps: Stock Rises 5.5% - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Ligand Pharmaceuticals Inc. ( LGND ) was a big mover last session, as the company saw its shares rise by over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained roughly 27% since Nov 7.

This healthcare company has seen a mixed track record when it comes to estimate revision with an upward and downward revision apiece in the past one month. The Zacks Consensus Estimate hasn't been in a trend either. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Ligand Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Some better-ranked stocks in the same industry include Jazz Pharmaceuticals Public Limited Company ( JAZZ ), Lannett Company, Inc. ( LCI ) and Questcor Pharmaceuticals, Inc. ( QCOR ). All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

JAZZ PHARMACEUT (JAZZ): Free Stock Analysis Report

LANNETT INC (LCI): Free Stock Analysis Report

LIGAND PHARMA-B (LGND): Free Stock Analysis Report

QUESTCOR PHARMA (QCOR): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: JAZZ , LCI , LGND , QCOR

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by